HIPAA Pharmaceutical Companies Presentation 
Pharma Marketing Network
MARCH 20, 2025
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. Regulatory agencies are demanding clearer disclosures and evidence-based claims in pharmaceutical promotions.
Pharma Marketing Network
OCTOBER 6, 2021
Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of third-party cookies, which all marketers must consider. Even brilliant creative is unlikely to attract attention when presented in a low-quality placement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
JANUARY 7, 2025
Pharmaceutical companies are leveraging AI and data analytics to create hyper-personalized campaigns. Navigating HIPAA regulations while tailoring messages requires careful planning and ethical decision-making. Additionally, the rise of social media marketing presents a new regulatory gray area.
Pharmaceutical Technology
OCTOBER 25, 2022
The multiple platforms and apps used in professional and personal lives present significant challenges for data management systems. Breaches of HIPAA in the US can result in fines of up to $50,000. A prime example of Cassie’s capabilities is a project Fairhurst has been working on for an international pharmaceutical company.
Expert insights. Personalized for you.
59 
Let's personalize your content